Trial purpose
Long-term follow-up
Tumor type
Multi-Cancer
Clinical summary
Summary
People who received AdaptImmune (ADP) adoptive cell therapy will be enrolled in this non-therapeutic, multi-centre, long-term follow-up (LTFU) study and will be followed for up to 15 years post-infusion of lentiviral vector-based adoptive cell therapy. Participants will be monitored for safety following last adoptive cell therapy infusion.
No treatments will be administered in this study.
Conditions
This trial is treating people with neoplasms who have completed ADP sponsored or supported clinical trials with adoptive cell therapy
Eligibility
Inclusion
- Participants who have received at least one dose of ADP adoptive cell therapy agent.
- Participants who have completed ADP sponsored or supported interventional study or have withdrawn from it.
- Participants who have completed treatment as part of managed access to a GSK adoptive cell therapy.
- Contraceptive use by men or women should be consistent with local regulations regarding the methods of contraception for those participating in clinical studies.
- The investigator is responsible for review of medical history.
- Capable of giving signed informed consent.
Inclusion
- You have previously participated in a certain specific clinical trial.
- You have had a certain type of treatment or surgical procedure.
Clinical trials have complex eligibility criteria, and other criteria may apply for this trial. Ask your doctor about whether this trial could be right for you.
More information
Trial Identifiers
Information on this page is partially produced from ClinicalTrials.gov *. View further details about this trial on the registry via the links below:
Trial sponsor
Adaptimmune
Scientific Title
Long-Term Follow-Up (LTFU) of Participants Treated With ADP Adoptive Cell Therapies
Get Support
You might find it helpful to speak to someone who has 'been there before'. Our Peer Connect program can provide one-on-one phone support from someone who understands what you're going through and has clinical trials experience.
Know more about Peer Connect
If you need cancer information and practical support for yourself, a carer, family or friend, contact Cancer Council to speak with an experienced health professional on 13 11 20.
Get support
Learn more about clinical trials through this collection of resources in languages other than English.
View information